Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Pipe

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Seminars in Hematology|April 25, 2006
Consideration in hemophilia therapy selectionSteven Pipe
Biologics : Targets & Therapy|August 27, 2009
Antihemophilic factor (recombinant) plasma/albumin-free method for the management and prevention of bleeding episodes in patients with hemophilia ASteven Pipe
Thrombosis Research|January 30, 2010
Visions in haemophilia careSteven Pipe
Seminars in Fetal & Neonatal Medicine|January 7, 2016
Perinatal hematologySteven Pipe
Thrombosis Research|January 7, 2012
Factors for life: advances in the treatment of congenital and coagulopathic bleeding disordersSteven Pipe, Barbara Zieger
Hematology. American Society of Hematology. Education Program|December 4, 2016
What is the role of an extended half-life product in immune tolerance induction in a patient with severe hemophilia A and high-titer inhibitors?Maissaa Janbain, Steven Pipe
Seminars in Fetal & Neonatal Medicine|March 8, 2006
Neonatal thromboembolic emergenciesCourtney Thornburg, Steven Pipe
Thrombosis Research|March 30, 2013
Innovations in coagulation: improved options for treatment of hemophilia A and BIngrid Pabinger-Fasching, Steven Pipe
Expert Review of Hematology|April 11, 2014
Factor VIII therapy for hemophilia A: current and future issuesLouis Aledort, Rolf Ljung, Kenneth Mann, et al.
American Journal of Hematology|June 8, 2026
Advances in Hemophilia: From Joint Health to FVIII Guidelines and the Clinical Integration of Rebalancing AgentsGuy Young, Annette von Drygalski, Steven Pipe, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Seminars in Hematology|April 25, 2006
Consideration in hemophilia therapy selectionSteven Pipe
Biologics : Targets & Therapy|August 27, 2009
Antihemophilic factor (recombinant) plasma/albumin-free method for the management and prevention of bleeding episodes in patients with hemophilia ASteven Pipe
Thrombosis Research|January 30, 2010
Visions in haemophilia careSteven Pipe
Seminars in Fetal & Neonatal Medicine|January 7, 2016
Perinatal hematologySteven Pipe
Thrombosis Research|January 7, 2012
Factors for life: advances in the treatment of congenital and coagulopathic bleeding disordersSteven Pipe, Barbara Zieger
Hematology. American Society of Hematology. Education Program|December 4, 2016
What is the role of an extended half-life product in immune tolerance induction in a patient with severe hemophilia A and high-titer inhibitors?Maissaa Janbain, Steven Pipe
Seminars in Fetal & Neonatal Medicine|March 8, 2006
Neonatal thromboembolic emergenciesCourtney Thornburg, Steven Pipe
Thrombosis Research|March 30, 2013
Innovations in coagulation: improved options for treatment of hemophilia A and BIngrid Pabinger-Fasching, Steven Pipe
Expert Review of Hematology|April 11, 2014
Factor VIII therapy for hemophilia A: current and future issuesLouis Aledort, Rolf Ljung, Kenneth Mann, et al.
American Journal of Hematology|June 8, 2026
Advances in Hemophilia: From Joint Health to FVIII Guidelines and the Clinical Integration of Rebalancing AgentsGuy Young, Annette von Drygalski, Steven Pipe, et al.
Pageof 3